` 0KHE (PerkinElmer Inc) vs S&P 500 Comparison - Alpha Spread

0KHE
vs
S&P 500

Over the past 12 months, 0KHE has underperformed S&P 500, delivering a return of -17% compared to the S&P 500's 10% growth.

Stocks Performance
0KHE vs S&P 500

Loading

Performance Gap
0KHE vs S&P 500

Loading
0KHE
S&P 500
Difference

Performance By Year
0KHE vs S&P 500

Loading
0KHE
S&P 500
Add Stock

Competitors Performance
PerkinElmer Inc vs Peers

S&P 500
0KHE
TMO
DHR
207940
LONN
Add Stock

PerkinElmer Inc
Glance View

Economic Moat
None
Market Cap
1T USD
Industry
Life Sciences Tools & Services

PerkinElmer Inc., originally founded in 1937, has evolved over the decades into a leading global innovator in the field of healthcare and life sciences. It began its journey by focusing on precision optics, but with time, the company strategically pivoted towards life sciences, diagnostics, and applied markets. This transformation harnessed its focus on innovative technologies that aid in the process of scientific discovery and clinical diagnostics. PerkinElmer primarily thrives on providing advanced solutions for detecting and analyzing biological and chemical compounds. With its robust portfolio of products and services, the company empowers laboratories and research institutions worldwide to unlock new insights into areas such as genetics, oncology, and environmental health. The company's revenue streams are multifaceted, embodying a mix of instruments, software, and services that cater to a variety of needs in the scientific and healthcare communities. PerkinElmer’s business model is anchored on selling sophisticated laboratory equipment like mass spectrometers, imaging systems, and diagnostic testing kits. Beyond equipment sales, the company also capitalizes on recurring revenue from consumables and services, ensuring a steady cash flow that supports its ongoing R&D efforts and market expansion initiatives. Furthermore, with a strategic emphasis on bolstering partnerships and acquisitions, PerkinElmer continually enhances its capability to deliver comprehensive solutions, thus maintaining its competitive edge in the ever-evolving scientific landscape. Through this, it manages to contribute not just to profitability but to a broader mission of improving global health outcomes.

0KHE Intrinsic Value
1.693 USD
Overvaluation 98%
Intrinsic Value
Price
P
Back to Top